Efficacy of low-density-lipoprotein lowering with statins.
作者信息
Seidel D, Cremer P
出版信息
Lancet. 1994 Sep 3;344(8923):683.
PMID:7915367
Abstract
摘要
相似文献
1
Efficacy of low-density-lipoprotein lowering with statins.
Lancet. 1994 Sep 3;344(8923):683.
2
Efficacy of low-density-lipoprotein lowering with statins.
Lancet. 1994 Sep 3;344(8923):683.
3
Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin.
Lancet. 1994 Jun 18;343(8912):1554-5. doi: 10.1016/s0140-6736(94)92945-9.
4
Efficacy of low-density-lipoprotein lowering with statins.
Lancet. 1994 Sep 3;344(8923):683-4.
5
Efficacy of low-density-lipoprotein lowering with statins.
Lancet. 1994 Sep 3;344(8923):684.
6
Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
Am J Cardiol. 1998 Feb 26;81(4A):1B-6B. doi: 10.1016/s0002-9149(98)00030-7.
7
A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients.
Atherosclerosis. 2002 Jun;162(2):363-71. doi: 10.1016/s0021-9150(01)00711-0.
8
Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
Lab Anim. 1992 Oct;26(4):269-80. doi: 10.1258/002367792780745689.
9
[Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
Rev Esp Cardiol. 1995 Jan;48(1):59-65.
10
[Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
Med Clin (Barc). 1995 Nov 25;105(18):719.
Zotero 插件